Cargando…
Structure-based identification of a new IAP-targeting compound that induces cancer cell death inducing NF-κB pathway
Inhibitors of apoptosis proteins (IAPs) are validated onco-targets, as their overexpression correlates with cancer onset, progression, diffusion and chemoresistance. IAPs regulate cell death survival pathways, inflammation, and immunity. Targeting IAPs, by impairing their protein–protein interaction...
Autores principales: | Cossu, Federica, Camelliti, Simone, Lecis, Daniele, Sorrentino, Luca, Majorini, Maria Teresa, Milani, Mario, Mastrangelo, Eloise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649670/ https://www.ncbi.nlm.nih.gov/pubmed/34938412 http://dx.doi.org/10.1016/j.csbj.2021.11.034 |
Ejemplares similares
-
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
por: Cossu, Federica, et al.
Publicado: (2019) -
Structure‐Activity Relationship of NF023 Derivatives Binding to XIAP‐BIR1
por: Sorrentino, Luca, et al.
Publicado: (2019) -
cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells
por: Majorini, Maria Teresa, et al.
Publicado: (2018) -
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors
por: Majorini, Maria Teresa, et al.
Publicado: (2022) -
Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-Mimetic
por: Cossu, Federica, et al.
Publicado: (2012)